Skip to content

Author

R. Pinninti

We have 3 of 53 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Clinical Heterogeneity and Survival Disparities in Leiomyosarcoma: An Exploratory Single-Center Retrospective Observational Study

Background: Leiomyosarcoma (LMS) is a rare aggressive sarcoma with substantial heterogeneity in anatomical presentation, stage, treatment, and survival. We evaluated clinical characteristics, treatment patterns, and survival, with particular emphasis on whether anatomical site independently predicted overall survival (...

R. Pinninti, K. Subramaniyan, R. Iyer et al. · 0 citations
Review Open access Sep 2026

Development of a Consensus-Based Risk Stratification Algorithm for HR+/HER2− Early Breast Cancer to Guide Adjuvant CDK4/6i Therapy: Outcomes from a Multidisciplinary Workshop in India

An evidence-informed, consensus-based tool to support recurrence risk stratification and treatment decision-making in patients with HR+/HER2– EBC, incorporating multidisciplinary perspectives and evolving evidence from guidelines and trials is developed.

K. Mallavarapu, R. Reddy B, Somashekhar Sp et al. · 0 citations
Open access Aug 2026

Impact of Molecular Classification on Multidisciplinary Treatment Decision Making in Early-Stage Endometrial Cancer: A Prospective Real-World Study From India.

Integration of molecular classification modified adjuvant treatment in approximately one fifth of patients, supporting the feasibility and clinical utility of molecularly integrated MDT decision making in early-stage endometrial cancer even in resource-constrained settings.

R. Pinninti, H. Abbaraju, Krishna Mohan Mallavarapu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.